Philip Morris International Inc. (PMI) suspends investments and activates plans to reduce manufacturing operations in the Russian Federation

Content of the article

NEW YORK — Regulatory news:

Philip Morris International Inc. (NYSE: PM) today announces the suspension of its planned investments in the Russian Federation, including all new product launches and commercial, innovation and manufacturing investments. PMI has also activated plans to scale back its manufacturing operations in Russia amid continued supply chain disruptions and the changing regulatory environment. We will continue to monitor developments.

Content of the article

“We have watched the war in Ukraine with amazement and condemn the violence in the strongest terms. We stand in solidarity with innocent men, women and children who are suffering,” said Jacek Olczak, CEO. “We join the many voices calling for an immediate end to the war and the restoration of peace.”

“Our immediate priority is the safety and security of our more than a thousand employees and their families in Ukraine. We have mobilized to carry out three critical missions: contributing to the evacuation of more than 800 people, to date, including from the most impacted areas; provide essential assistance to employees who remain in Ukraine; and provide those who have left the country with logistical, medical, financial and other practical support in neighboring countries. We continue to pay salaries to all of our Ukrainian employees during this period. »

PMI continues to support humanitarian efforts, provide assistance and do everything possible for our employees and the people of Ukraine. We have delivered shipments of food, medicine and other basic necessities, in partnership with NGOs in several countries. In a recent five-day period, our employees donated over $300,000 to support relief efforts through our employee-led charitable program, Projects with a Heart. PMI will match these donations. Additionally, PMI pledged an initial $10 million to support international humanitarian efforts.

Jacek Olczak added: “Given the situation, the Board of Directors and our management team have decided to suspend all of our planned investments in Russia and to activate plans to reduce our manufacturing operations. We will support our employees in Russia during this time, including by continuing to pay their salaries. »

Notes to Editors

PMI entered the Ukrainian market in 1994. On February 25, 2022, PMI announced the temporary suspension of its operations in Ukraine, including its factory in Kharkiv. In 2021, Ukraine accounted for approximately 2% of PMI’s total cigarette and heated tobacco unit shipment volume and less than 2% of PMI’s total net revenue. The company has a factory and about 1,300 employees in the country and has contingency plans in place to restart product supply once security conditions permit.

In 2021, Russia accounted for nearly 10% of PMI’s total cigarette and heated tobacco unit shipment volume and about 6% of PMI’s total net revenue. PMI opened its first representative office in Russia in 1992 and has over 3,200 employees in the country.

Content of the article

Philip Morris International: Delivering a smoke-free future

Philip Morris International (PMI) is a leading international tobacco company striving to deliver a smoke-free future and evolving its long-term portfolio to include products outside of the tobacco and nicotine industry. The Company’s current product portfolio consists primarily of cigarettes and smokeless products, including non-combustion heat, vapor and oral nicotine products, which are sold in markets outside of the United States. Since 2008, PMI has invested more than $9 billion to develop, scientifically support, and market innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of ending the sale of cigarettes altogether. This includes developing world-class scientific evaluation capabilities, including in the areas of preclinical systems toxicology, clinical and behavioral research, and post-marketing studies. The United States Food and Drug Administration (FDA) has cleared a version of PMI for sale IQOS Platform 1 Device and Consumables as a Modified Risk Tobacco Product (MRTP), concluding that an exposure modification order for these products is appropriate to promote public health. As of December 31, 2021, PMI’s smoke-free products are available for sale in 71 markets, and PMI estimates that approximately 15.3 million adults worldwide have already switched to IQOS and quit smoking. With a solid foundation and significant expertise in the life sciences, in February 2021, PMI announced its ambition to expand into the areas of wellness and health and provide innovative products and solutions that aim to meet the unmet needs of patients and consumers. For more information, please visit and

See the source version on



Contact details (international)
Tommaso de Giovanni
Philip Morris International
T. +41 (58) 242 6748
[email protected]

Contact (US and UK)
corey henry
Philip Morris International
T +1 (202) 777 4304
[email protected]


Comments are closed.